Mea Hoʻolālā Peptides & Hoʻohui Kuʻuna: Kanal i ka Neuro Scaffolds

Pane wikiwiki

How designer research peptides — from channel blockers to neuroprotective candidates — dictate custom synthesis, pilikia hoʻohui, lepili, ka maemae, and assay-…

No ke aha o ka Scaffold ka mea kiko'ī

ʻO kahi "peptide mea hoʻolālā" ʻaʻole ia he kaula laina maʻalahi. ʻO nā papa hana e hoʻomalu nei i ke kahawai a me ka palapala CNS e koi ana i ke kumu.

ʻO nā mea hoʻopaʻa ion-channel i loaʻa mai ke ʻano maoli he mau toxins waiwai nui i disulfide. Scorpion α-KTx peptides, ʻo kahi laʻana, e hoʻopaʻa i kahi paʻi paʻa me ʻekolu a ʻehā mau mea paʻa disulfide, a ʻo kēlā ʻano cysteine ​​paʻa paʻa ka mea e hiki ai iā lākou ke hoʻopaʻa i loko o ka pore-kanal potassium me ka hoʻokae ʻano subtype.. E hana hou i kēlā ʻano hana synthetic, a lilo kēlā me kēia cysteine ​​i pilikia regioselectivity: Hiki i nā cysteine ​​ʻeono ke hoʻohui i nā isomer disulfide he ʻumikūmālima, a hoʻokahi wale nō hoʻonohonoho e hoʻopili hou i ka conformation hana.

Hoʻohuihui Peptide Mea Hoʻolālā Peptides & Hoʻohui Kuʻuna: Kanal i ka Neuro Scaffolds

Noho nā moho neuroprotective ma ka ʻaoʻao ʻē aʻe akā hāpai i nā hopohopo kiʻi aniani. ʻO kā lākou mau kaʻina hana he pōkole a me ka protease-sensitive, no laila hiki i nā pūʻulu no ke kemika iwi kuamoʻo - ʻO ka cyclization a me ka stapling nā ala maikaʻi loa e hoʻopaʻa i kahi conformation ikaika a pale aku i ka hōʻino, e like me ka hana ma ka nerinetide a me nā peptides CNS pili. ʻO ke kumukūʻai synthetic maoli: ʻO ka macrocyclization a i ʻole ka hydrocarbon staple e hoʻohui i nā ʻanuʻu pane, hana i ka lehulehu haumia hou, a koi ʻoe e hōʻoia i ka palapala pani, ʻaʻole wale ka laina mua.

He mea maʻalahi ke ʻano o kēia no ka synthesis maʻamau. ʻAʻole wehewehe ʻia kahi peptide e kāna kaʻina mua wale nō akā ma o kāna paʻi i manaʻo ʻia, kona topology cysteine, ʻO nā Peptides Synthetic kona wahi cyclization, a me nā hōʻailona e lawe ai. ʻO kēlā me kēia mea he hoʻoholo āu e kau ai ma ka pōkole synthesis ma mua o kahi hui hoʻokahi.

Mea Hoʻolālā Peptides & Hoʻohui Kuʻuna: Kanal i ka Neuro Scaffolds

ʻO ka hui ʻana ke ʻano hana ʻino mua

ʻAʻohe waiwai peptide e wāwahi i nā papahana ma mua o ka hōʻuluʻulu ʻana. I ka wā o ka hui pū ʻana o Fmoc, nā kaulahao e ulu ana he hydrophobic a i ʻole β-sheet-prone pilikino pilikino ma o ka pilina hydrogen intermolecular pololei ma ka resin.. ʻO ka hāʻule ʻana o ka bead e ālai ana i ke komo ʻana o nā waikawa amino i hoʻāla ʻia, hana i nā hui like ʻole, a kākau i ka ʻoki ʻana a me ka holoi ʻana i nā mea haumia i loko o ke kaʻina ma mua o ka hoʻomaka ʻana o ka hoʻomaʻemaʻe.

ʻIke maikaʻi ʻia ka mīkini i kēia manawa. ʻO ka hana hou ma Nature Chemistry e hōʻoia i ka hoʻohui ʻana o ka waikawa amino i ka hoʻohui ʻana i ka wā peptide synthesis., e hōʻike ana i ke kaʻina ponoʻī - ʻaʻole i kona lōʻihi wale nō - e hoʻomalu i ke kaulahao i pale ʻia i loko o ka hoʻolālā lua obstructive ma ke kākoʻo.. Kūlike kēia me ka mōʻaukala lōʻihi o ka noiʻi ʻana i nā mea i kapa ʻia ʻo "nā kaʻina paʻakikī,” ka mea ua ʻimi ke kahua i ka hoʻokumu ʻana i ka β-pepa ma-resin ka mea e keakea ana i ka hoopili ana a me ka deprotection.

ʻElua mau hōʻailona kūpono e wānana i ka pilikia ma mua o ka holo ʻana o kahi moku:

  • Holo hydrophobic pili waiwai ma Val, Me, Leu, a me Phe. ʻO kēia nā mea hoʻokele maʻamau o ka resin collapse.

  • ʻO kahi uku ʻupena kokoke ʻole. Me ka ʻole o ka Coulombic e hoʻopaʻa i nā kaulahao i ka hoʻonā, ʻO nā pilina hydrophobic e hoʻomalu a hoʻoheheʻe ka peptide a i ʻole nā ​​gels i ka wā o ka cleavage a me ka assay buffer..

No ka mea, ʻo ka channel-blocker a me nā scaffolds neuroprotective lean hydrophobic a hana pinepine ma kahi kokoke i ko lākou isoelectric point., ʻO kā lākou hōʻuluʻulu pilikia he structural, ʻaʻole pili. Ka mālama ʻana iā ia - ma o nā hoʻokomo pseudoproline, hōʻailona hoʻoheheʻe, pale kuamoʻo, haʻahaʻa resin hoʻouka, a i ʻole ka hui ʻana i kōkua ʻia i ka microwave - he ʻāpana o ka mākaukau i hoʻonohonoho ʻia e ka hoa hana synthesis e lawe maoli mai, ʻaʻole kahi laina lawelawe maʻamau. ʻO ka manaʻo o ka mea kūʻai aku e hōʻailona mua i ka pilikia a koi i ka mea hoʻolako e haʻi pehea e hoʻomalu ʻia ai.

Lepili a me ka Hoʻololi: He Hoʻoholo Hoʻolālā kēlā me kēia Tag

Ma kahi kokoke i kēlā me kēia peptide noiʻi hoʻāʻo e hoʻopau i kahi mea: he lāʻau biotin no ka hopu ʻana, he fluorophore no ke kiʻi a hoʻopaʻa ʻana, he CPP no ka lawe ʻana, he PEG a i ʻole lipid no ke kūpaʻa. Hoʻohana pinepine ʻia ka lepili ma ke ʻano he manaʻo hope. ʻAʻole ia - he mole lua ia i hoʻopili ʻia i ka mua.

Hiki ke hoʻololi i ka ʻano o nā lepili. A 2024 Ua ʻike ʻia ka noiʻi ʻana ua hoʻololi ka lepili fluorescent i ka hoʻokaʻawale ʻana i ka peptide-protein mau ma kahi ʻano o ka nui., me ka hopena ma muli o ka fluorophore a me ka hoa paʻa. ʻO nā waiʻona hydrophobic a i hoʻopaʻa ʻia ka mea hewa loa no ka mea ke hoʻololi nei lākou i ka hoʻohui ʻana a me ka adsorption ʻili ʻole.. ʻOi aku ka liʻiliʻi o ka biotinylation akā hoʻopilikia mau i ka mole, e hoʻonui ana i ka hydrophobicity a me ka hōʻemi ʻana i ka uku ma nā ala e hoʻololi ai i ka hana ʻana o ka peptide ma kahi kolamu LC-MS a me nā hoʻokolohua hopu..

Hiki ke hoʻololi ʻia nā lula e pili ana i kēlā me kēia scaffold ma ke kahawai-a-CNS spectrum:

  • E mālama i ka pharmacophore maʻemaʻe. E kau i ka hōʻailona ma ka hopena i ʻike ʻole ʻia i ka solvent a i ʻole ma ke koena i ʻike ʻole ʻia e hoʻopā i ka pahu hopu.

  • E hoʻokaʻawale i ka lepili mai ke kumu bioactive me kahi spacer e like me ka aminocaproic acid (Ahhh) a i ʻole kahi loulou PEG pōkole i ka wā e pono ai nā steric.

  • E ho'āʻo ma mua o hoʻokahi pūnaewele inā maopopo ʻole ka epitope paʻa - hiki i kahi peptide maʻalahi a i ʻole kekahi hapa ke ʻae ʻia i kahi kala ma kahi palena a ʻaʻole kekahi..

  • E hōʻike i ka hana i hōʻailona ʻia e like me kona mole ponoʻī, ʻAʻole loa ma ke ʻano he mea koho leo no ka peptide unlabeled. E hōʻoia i ka pilina a me ka hana no nā ʻano ʻelua.

No nā scaffolds waiwai disulfide a i ʻole cyclized aia kekahi kaohi: ʻAʻole pono ka hoʻokomo ʻana i ka lepili e hoʻopilikia i ka kemika pelupa a i ʻole cyclization, no laila nā lima kikoʻī pūnaewele (no ka laʻana he lysine i pale ʻia a i ʻole cysteine) Hoʻokomo pinepine ʻia ma ka resin ma mua o ka deprotection hope.

ʻO ka maʻemaʻe kahi hoʻoholo noi, ʻAʻole He helu

ʻO ka maʻemaʻe āu e noi ai e hahai i ka mea e pono ai ka assay, a ʻo "kiʻekiʻe" ʻaʻole ia he kikoʻī. Hoʻokumu maikaʻi ʻia nā paepae kūpono ma waena o nā mea hoʻolako a me nā palapala ʻenehana:

  • ≥95% maʻemaʻe HPLC kākoʻo i ka hapa nui o nā bioassays in vitro, hana antibody, a me nā haʻawina semi-quantitative.

  • ≥98% ʻo ia ka papahele kūpono no ka quantitative, ma ke kelepona, a me nā hoʻokolohua hoʻopaʻa hoʻopaʻa ʻana i kahi a 2% hiki i ka hui haumia ke hoʻololi i kahi heluhelu.

  • >98–99% mālama ʻia no ka hana ʻenehana koʻikoʻi a no nā haʻawina e pili ana i nā koi kumu hoʻopukapuka..

Ma kahi e hoʻopili ai nā scaffolds a me nā neuro he mea maʻalahi kēia: he peptide cyclized a stapled i hoʻomaʻemaʻe ʻia i 98% ʻAʻole pau ka maʻemaʻe laina inā ʻaʻole i pani ʻia kahi hakina kūpono i ke ʻano pōʻaiapili pololei. Pono e hoʻokomo i ka spec maʻemaʻe kūpono i ka pelu pololei, ʻano ʻano paikikala pololei, ʻaʻole kahi helu hui e hui pū ai. ʻO ia ke kumu e nīnau ai nā mea kūʻai aku i nā mea kūʻai aku pehea ka wehewehe ʻana o ka maʻemaʻe i kēlā me kēia ʻano like ʻole a koi ʻia e hōʻike ka Certificate of Analysis i ke ʻano i manaʻo ʻia..

Pono like ka pono o lalo. No ka hoʻāʻo ʻana ma ke kelepona, ʻAʻole pili ka maʻemaʻe wale i ka sterility a i ʻole ka ukana endotoxin, ʻO ia ke kumu e hoʻokaʻawale ai nā ʻōnaehana maikaʻi i ka maʻemaʻe chromatographic mai ka microbial a me ka pyrogen content. Hiki i kahi peptide 99% maʻemaʻe e ka HPLC a ke lawe mau nei i ka lipopolysaccharide e hoʻopau i kahi hoʻāʻo koʻikoʻi. E wehewehe i ka pūʻulu piha o nā hiʻohiʻona maikaʻi āu e pono ai, ʻaʻole pākēneka wale nō.

Hōʻike ʻia nā ʻano hoʻomākaukau hoʻāʻo, Aole Maemae wale

ʻO ka huaʻōlelo "mākaukau hoʻāʻo" kahi e paʻa a haki paha ka nui o nā pilina mea hoʻolako. Mākaukau wale ka peptide no ka biology hilinaʻi inā kona ʻike, kaʻina, a ua hōʻoia ʻia ka ʻike, ʻaʻole wale inā he maʻemaʻe kona piko HPLC nui.

ʻO ka puʻupuʻu hilinaʻi liʻiliʻi no ka hoʻohana hana ʻana me ka RP-HPLC analytical no ka maʻemaʻe o ka wahi kiʻekiʻe, mass spectrometry e hōʻoia i ka paona molekala paʻa, a - kahi e hōʻoia ʻia ai ka ʻoiaʻiʻo a i ʻole ka hoʻololi ʻana - MS/MS peptide mapping. No ka hana quantitative, Pono e hoʻohana ʻia ka loiloi amino acid e hoʻoponopono i ka ʻike maoli o ka peptide, no ka mea, ʻo ka hoʻokaʻawale ʻana i ka nui o ke kaupaona ʻana ma mua o ka ʻike peptide net ʻoiaʻiʻo he kumu mālie ia o ka hewa e hoʻolaha ʻia ma kēlā me kēia neʻe ʻana i lalo.. ʻO kēia nā mea Manaʻo ke alakaʻi e pili ana i ka assay e hoʻopili ʻia i kahi palapala hōʻoia.

Aia kahi āpau i kākau maikaʻi ʻia ua lohi ka pani ʻana o ke kahua. A 2019 ʻIke ʻia ka nānā ʻana i nā peptides synthetic o kahi o 20-100 mau koena ʻaʻole i hōʻike pinepine ʻia i ko lākou pelu ʻana a me ka hoʻolālā ʻekolu-dimensional., ʻoiai ke hōʻike ʻia ka maʻemaʻe a me ke kaʻina. No ka disulfide-rich channel blocker a i ʻole ka moho neuroprotective cyclized, ʻO ka hōʻoia ʻana i ka paʻi pololei a me ka disulfide a i ʻole ka cyclization topology he mea nui e like me ka maʻemaʻe - kahi isomer hewa a i ʻole kahi precursor paʻa ʻole hiki ke noho mālie a hoʻopunipuni paha.. ʻO ka wehewehe ʻana i kēia mau ʻae ʻana i mua, a me ka nīnau ʻana i nā ʻano orthogonal (hui pu ana, Palapala palapala MS/MS, CD, a i ʻole conformational assays) e hoʻohana ʻia e hōʻoia i ke kūlana i manaʻo ʻia, ʻo ia ka nīnau kiʻekiʻe loa e hiki i ka mea kūʻai ke nīnau.

Ke Ki'i 'ana i ka Peptide Synthesis no nā Scaffolds pa'akikī

ʻO ka mea e hoʻohui i kēia mau mea āpau, ʻo ia ka hiki ʻana o ka peptide synthesis maʻamau ʻaʻole e pili ana i ka hoʻokuke ʻana i kahi kaʻina maikaʻi ma o kahi laina maʻamau.. E pili ana i ke ala hoʻohālikelike i ka scaffold - kaohi ʻana i ka hōʻuluʻulu ʻana ma nā kaʻina hydrophobic paʻakikī, ka hoʻokomo ʻana i nā lepili kikoʻī pūnaewele me ka haki ʻole ʻana i kahi hoʻolālā disulfide, kaʻa paikikala a stapling me ka waiho ʻole ʻana i nā huahana pani ʻia, a me ke kākoʻo ʻana i kēlā me kēia koi me ka HPLC pākahi, nuipaʻa, sterility, a me ka ʻikepili maʻiʻo. I ka wā e paʻa ai kēlā mau mana, lilo ka hoʻololi ʻana i ka neuroprotective i kahi pilikia kemika ma kahi o ka piliwaiwai mea kūʻai aku. Hana ʻia ʻo Peptide

No nā hui e kūkulu nei i kēia mau scaffold koi, ʻO ka MOL Changes 'kūlana peptide synthesis platform kākoʻo i ka hui ʻana o nā ʻenehana e pono ai ka noiʻi - solid-phase, wai wai, a me nā ala fermentation microbial, pau 300 kemika hoʻololi me ka cyclic, hoʻopaʻa ʻia, biotinilated, a me nā peptides i hōʻailona ʻia, maemae a hiki i 99%, a Papa 100 hana sterile me ka HPLC a me nā palapala kikoʻī nui mai ka milligram a hiki i ka paona kilo. E kūkākūkā ana i kāu kaʻina, kona papa i manaoia, a ʻo kāna mau koi hoʻāʻo i mua ʻo ia ke ala wikiwiki loa e hoʻohuli i kahi peptide mea hoʻolālā mai kahi kiʻi i loko o kahi pūʻulu hiki iā ʻoe ke hilinaʻi i ka lab..

Xiaoxia Chen

Xiaoxia Chen

Laau Laau Hou R&D ʻenehana Kaʻike kumu: Loaʻa ka pahuhopu, pilina hana-hana (SAR) kālailai, peptide-lāʻau conjugates (Nā PDC), a me ka hoʻomohala ʻana i nā peptides anti-kahiko a me ka metabolic.

Pilikino: Ua alakaʻi ʻo Xiaoxia Chen i ka ʻike mua ʻana a me ka noiʻi preclinical no kekahi mau lāʻau peptide metabolic a me ka tumor-targeted.. ʻAʻole wale ʻo ia i mākaukau i ka nānā ʻana i nā hale waihona puke peptide, akā akamai nō hoʻi i ka hoʻohana ʻana i ka biology computational kōkua AI no ka hoʻolālā ʻana o ka de novo peptide sequence.. I kēia manawa, ke alakaʻi nei ʻo ia i kahi hui i hoʻolaʻa ʻia i ka noiʻi hohonu a me ka hoʻomohala ʻana o nā agonists multifunctional hanauna hou (like me pālua- a i ʻole nā ​​peptides hoʻohaʻahaʻa momona ʻekolu) a me nā peptides hoʻoponopono hou i ke kino.

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana